Schrodinger Inc.
- BID
13.225
- ASK
13.28
- 1,512 Units1,506 Units
- 07/21, 17:29:21 PM
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
28.62%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-1.25 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 13.255 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 05:18:55 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 13.35 | 12.955 |
| PREV. DAY'S PRICE | 13.17 | (07/20) |
| CHANGE DAY BEFORE | +0.09 | 0.65 % |
| 52 WEEK HIGH / LOW | 19.725 (07/22) | 9.364 (02/24) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.50 | -2.38 | -1.25 | -1.71 | -1.37 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | 65.93 | - | - | - | - |
PRICE - BOOK RATIO | 4.71 | 3.34 | 3.62 | - | - |
PRICE - SALES RATIO | 12.39 | 6.75 | 5.13 | - | - |
PRICE - CASH FLOW RATIO | 256.16 | - | 94.48 | - | - |
Master Data
| WKN | A2PY7M |
| ISIN | US80810D1037 |
| SYMBOL | 43Z |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | SCHRODINGER INC.DL -,01 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -8.92 % | -2.66 % | 22.00 % | -5.63 % | -28.62 % | - | - | -12.23 % |
| HIGH | 14.51 | 15.43 | 15.43 | 15.43 | 19.73 | - | - | 16.47 |
| LOW | 13.12 | 12.80 | 9.62 | 9.36 | 9.36 | - | - | 9.36 |
Dividende
pro Aktie
SCHRODINGER INC.DL -,01 does not deliver dividend information
Company profile
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.
Structured products for Schrodinger Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.